Nephrolithiasis: FDA reporting patterns
45,138 FDA FAERS reports mention Nephrolithiasis. 40,841 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 3,236 reports
- Infliximab: 2,158 reports
- Etanercept: 1,929 reports
- Topiramate: 1,143 reports
- Methotrexate: 1,053 reports
- Interferon Beta-1a: 1,009 reports
- Sodium Oxybate: 992 reports
- Esomeprazole: 991 reports
- Teriparatide: 925 reports
- Certolizumab Pegol: 843 reports
- Abatacept: 824 reports
- Rituximab: 817 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.